Neuralink
Overview Neuralink is an American neurotechnology company founded in 2016 by Elon Musk, with headquarters in Fremont, California. The company develops implantable brain-computer interfaces (BCIs) and is focused on creating high-bandwidth neural interfaces to treat neurological conditions and ultimately achieve human-AI symbiosis[@neuralink].
Company Overview | Attribute | Details | |-----------|---------| | Headquarters | Fremont, California, USA | | Founded | 2016 | | Founder | Elon Musk | | CEO | Elon Musk | | Employees | ~300+ | | Funding | ~80 million |
Technology
N1 Implant Neuralink's flagship product is the N1 implantable brain-computer interface:
Electrode Count : 1,024 electrodes across 64 threads
Thread Diameter : 5 microns (human hair is ~75 microns)
Wireless : Fully implantable, wireless data transmission
Battery : Rechargeable inductive charging
Size : Coin-sized implant
The Link The Link is the subcutaneous receiver that:
Processes neural signals from the electrode threads
Wireless transmits data to external devices
Recharges via inductive charging
Contains the electronics for signal amplification and digitization
Surgical Robot Neuralink developed a custom surgical robot (R1) to implant the threads:
Precise insertion of micro-electrodes
Avoids blood vessels during insertion
Minimizes tissue damage
Fully automated placement procedure
Clinical Trials
PRIME Study ...
Neuralink
Overview Neuralink is an American neurotechnology company founded in 2016 by Elon Musk, with headquarters in Fremont, California. The company develops implantable brain-computer interfaces (BCIs) and is focused on creating high-bandwidth neural interfaces to treat neurological conditions and ultimately achieve human-AI symbiosis[@neuralink].
Company Overview | Attribute | Details | |-----------|---------| | Headquarters | Fremont, California, USA | | Founded | 2016 | | Founder | Elon Musk | | CEO | Elon Musk | | Employees | ~300+ | | Funding | ~80 million |
Technology
N1 Implant Neuralink's flagship product is the N1 implantable brain-computer interface:
Electrode Count : 1,024 electrodes across 64 threads
Thread Diameter : 5 microns (human hair is ~75 microns)
Wireless : Fully implantable, wireless data transmission
Battery : Rechargeable inductive charging
Size : Coin-sized implant
The Link The Link is the subcutaneous receiver that:
Processes neural signals from the electrode threads
Wireless transmits data to external devices
Recharges via inductive charging
Contains the electronics for signal amplification and digitization
Surgical Robot Neuralink developed a custom surgical robot (R1) to implant the threads:
Precise insertion of micro-electrodes
Avoids blood vessels during insertion
Minimizes tissue damage
Fully automated placement procedure
Clinical Trials
PRIME Study Neuralink's first-in-human clinical trial is called PRIME (Precise Robotically Implanted Brain-Computer Interface):
Identifier : NCT05126784
Status : Recruiting
Target : Patients with quadriplegia due to spinal cord injury or ALS
Primary Endpoint : Safety and device functionality
First Human Implant (2025) In January 2025, Neuralink announced successful implantation of the N1 device in their first human patient:
Patient demonstrated ability to control computer cursor using neural signals
Successfully played chess and interacted with software
Demonstrated high-accuracy motor intent decoding (>90%)
No serious adverse events reported in initial cohort[@neuralink2025]
Second Patient Neuralink has implanted devices in additional patients as part of the PRIME study, expanding clinical experience with the technology.
Applications
Initial Target Indications
Quadriplegia : Enable patients with spinal cord injuries to control computers and devices
ALS : Restore communication abilities for patients with late-stage ALS
Blindness : Blindsight program for visual cortex stimulation
Future Applications
Human-AI Symbiosis : Musk's stated long-term goal is to enable humans to interface with AI
Memory Augmentation : Potential for cognitive enhancement in Alzheimer's disease
Treatment of Neurological Conditions : Depression, addiction, PTSD (speculative)
Competitive Landscape Neuralink competes with other BCI companies:
| Company | Technology | Status | |---------|------------|--------| | Blackrock Neurotech | Utah Array | FDA Approved | | Synchron | Stentrode | FDA IDE approved | | Paradromics | High-density array | Clinical trials | | Precision Neuroscience | Layer 7 array | Preclinical |
Regulatory Status
FDA Breakthrough Device Designation : Granted for the N1 device
FDA Approval for Human Trials : PRIME study approved
Human Trials : Ongoing (2025-present)
Technical Advantages
Advantages over Competing Technologies
Highest Channel Count : 1,024 electrodes vs. ~100-300 for competitors
Wireless : Fully implantable with no percutaneous connections
Flexible Threads : Reduce tissue damage and immune response
Robotic Implantation : Precise, consistent placement
Advanced Signal Processing : Machine learning for neural decoding
Challenges
Long-term Safety : Limited long-term data on implant safety
Durability : Questions about device longevity
Manufacturing : Scaling production of complex devices
Cost : Currently extremely expensive
Research Publications
Key Publications
Musk et al. Neuralink: An integrated brain-machine interface. Journal of Neural Engineering . 2022.
Neuralink has published preprint papers on electrode design and surgical techniques, though peer-reviewed clinical data is still emerging.
Cross-References
Blackrock Neurotech - Competing BCI company
Synchron - Competing BCI company
Paradromics - Competing BCI company
Related Pages
Brain-Computer Interface Technology Landscape
BCI Company Comparison Matrix
[Motor Cortex](/brain-regions/motor-cortex)
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) (ALS)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Spinal Cord Injury](/diseases/spinal-cord-injury)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Cell Types Overview](/companies/overview)
[Gene Overview](/companies/overview)
[Disease Overview](/companies/overview)
External Links
[Neuralink Website](https://neuralink.com/)
[PRIME Study Clinical Trial](https://clinicaltrials.gov/study/NCT05126784)
[Neuralink Blog](https://neuralink.com/blog/)
References
Unknown, Neuralink Corporation. Company Website (n.d.)
Unknown, Neuralink. First Human Results. PRIME Study (2025) (2025)
Show full description